|
|
|
|
|
|
|
Moleculin Biotech CS (MBRX)
|
|
1.87 0.01 (0.54%)
|
04-18 16:00
|
|
Open:
|
1.84
|
Pre. Close:
|
1.86
|
|
High:
|
1.89
|
Low:
|
1.84
|
|
Volume:
|
112,729
|
Market Cap:
|
48M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
1.893 - 1.903
|
1.903 - 1.913
|
|
Low:
|
1.812 - 1.826
|
1.826 - 1.839
|
|
Close:
|
1.85 - 1.87
|
1.87 - 1.888
|
|
|
|
Technical analysis (as of: 2018-04-18 4:42:23 PM)
|
|
Overall:
|
|
|
Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.
|
|
Target:
|
Six months: 2.35  One year: 2.53
|
|
Support:
|
Support1: 1.75 Support2: 1.46
|
|
Resistance:
|
Resistance1:
2.01 Resistance2: 2.17
|
|
Pivot:
|
1.84 
|
|
Moving Averages:
|
MA(5): 1.87 MA(20): 1.87
MA(100): 1.88 MA(250): 1.84
|
|
MACD:
|
MACD(12,26):
-0.03 Signal(12,26,9): -0.03
|
|
%K %D:
|
%K(14,3): 59.67 %D(3): 53.42
|
|
RSI:
|
RSI(14): 47.84
|
|
52-Week:
|
High: 3.75
Low: 0.7064 Change(%): 112.5
|
|
Average Vol(K):
|
3-Month: 109580
10-Days 19273
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.MBRX has closed below upper band by 30.2%. Bollinger Bands are 69.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to MBRX's normal range. The bands have been in this narrow range for 5 bars. This is a sign that the market may be about to initiate a new trend.
|
|
|
Headline News
|
|
2018-03-28T08:33:34-04:00
Moleculin Biotech reports FY results
2018-02-21T13:37:37-05:00
Moleculin completes roundtrip after "cancer breakthrough"- stoked up move
2018-02-16T12:44:12-05:00
Midday Gainers / Losers (2/16/2018)
2018-02-16T09:16:06-05:00
Premarket Losers as of 9:05 am (2/16/2018)
2018-02-15T12:40:15-05:00
Midday Gainers / Losers (2/15/2018)
2018-02-15T10:23:51-05:00
Moleculin announces "major breakthrough" in cancer treatment; shares up 54%
2018-02-15T09:21:15-05:00
Premarket Gainers as of 9:05 am (02/15/2018)
2018-01-10T09:24:17-05:00
Premarket Gainers as of 9:05 am
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
